There were an estimated 47 million to 82 million flu illnesses in the United States between October 2024 and May 2025.

The FDA has approved an at-home nasal spray flu vaccine, and it’s now available for order. FluMist enters the bloodstream ...

The new AAP schedule provides guidance for routine immunization against 18 diseases, including updates for RSV, influenza, and COVID-19 immunization.

Influenza infections are emerging as the primary driver behind the recent surge in viral fever cases across the country, with ...

FluMist Home is an influenza vaccine that’s administered via nasal spray, which means no needles and no waiting in line at ...

AstraZeneca has issued its flu vaccine nasal spray for at-home use. The nasal spray is authorized for use by adults ages 18-49 and for caregiver use with children ages 2-17, according to an Aug. 15 ...

AstraZeneca has launched FluMist Home, a nasal spray flu vaccine with at-home delivery service. For those who have a needle ...

This new option, known as FluMist, was released Friday and is the same vaccine formulation that has been available in doctors' offices for decades. Also in the news: covid, measles, and rabies.

The FDA approved AstraZeneca’s no-prescription FluMist vaccine in September 2024. Now with FluMist Home, people can have it ...

Michigan offers FluMist nasal vaccine delivery, aiming to increase flu vaccinations with the convenience of home administration for individuals aged 2 to 49.

A poll published Aug. 1, 2025, by the health policy organization KFF found half of parents are unsure whether federal health ...

The approval of the new nasal spray comes ahead of this year's influenza season in hopes to prevent the unusually high ...